Development of a Mouse Glioblastoma Orthotopic Model Using the GLi-261 Cell Line
Glioblastoma is the most common and most aggressive type of brain tumor, with an almost 100 % mortality rate over 5 years. The search for new effective approaches to the treatment of this disease requires the development of adequate experimental models. Objective: to develop and put into practice an...
Main Authors: | A. A. Borzov, A. A. Оvsepyan, E. I. Katorkina, E. O. Anisimova, M. V. Lykov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-12-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/252 |
Similar Items
-
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide
by: Alexandra M. Mowday, et al.
Published: (2020-06-01) -
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01) -
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma
by: Monserrat Llaguno-Munive, et al.
Published: (2018-12-01) -
The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
by: Mira A. Patel, et al.
Published: (2014-09-01) -
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
by: Xue Song, et al.
Published: (2018-09-01)